Showing results (731-740 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|April 28, 2019
Two-pore physiologically based pharmacokinetic model with de novo derived parameters for predicting plasma PK of different size protein therapeuticsZhe Li, Dhaval K ShahJournal of Pharmacokinetics and Pharmacodynamics|October 17, 2021
A longitudinal model for the Mayo Clinical Score and its sub-components in patients with ulcerative colitisSonoko Kawakatsu, Rui Zhu, Wenhui Zhang, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 29, 2022
Towards a translational physiologically-based pharmacokinetic (PBPK) model for receptor-mediated transcytosis of anti-transferrin receptor monoclonal antibodies in the central nervous systemHsueh-Yuan Chang, Shengjia Wu, Ekram Ahmed Chowdhury, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 1, 2022
Two heads are better than one: current landscape of integrating QSP and machine learning : An ISoP QSP SIG white paper by the working group on the integration of quantitative systems pharmacology and machine learningTongli Zhang, Ioannis P Androulakis, Peter Bonate, et al.Journal of Pharmacokinetics and Pharmacodynamics|May 23, 2019
A translational platform PBPK model for antibody disposition in the brainHsueh-Yuan Chang, Shengjia Wu, Guy Meno-Tetang, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 28, 2021
Population pharmacokinetic model selection assisted by machine learningEmeric Sibieude, Akash Khandelwal, Pascal Girard, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 23, 2021
A Bayesian population physiologically based pharmacokinetic absorption modeling approach to support generic drug development: application to bupropion hydrochloride oral dosage formsNan-Hung Hsieh, Frédéric Y Bois, Eleftheria Tsakalozou, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 16, 2018
Extrapolation of praziquantel pharmacokinetics to a pediatric population: a cautionary talePeter L Bonate, Tianli Wang, Paul Passier, et al.Journal of Pharmacokinetics and Pharmacodynamics|August 11, 2020
Composite midazolam and 1'-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activitySabrina T Wiebe, Andreas D Meid, Gerd MikusJournal of Pharmacokinetics and Pharmacodynamics|August 2, 2012
Dynamics of target-mediated drug disposition: characteristic profiles and parameter identificationLambertus A Peletier, Johan GabrielssonPageof 107